KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

por Tabernero, Josep, Bang, Yung-Jue, Van Cutsem, Eric, Fuchs, Charles S, Janjigian, Yelena Yuriy, Bhagia, Pooja, Li, Kan, Adelberg, David, Qin, Shu Kui
Publicado 2021

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

por English, Bevin C, Baum, Caitlin E, Adelberg, David E, Sissung, Tristan M, Kluetz, Paul G, Dahut, William L, Price, Douglas K, Figg, William D
Publicado 2010